Skip to main content

Table 3 Cross-sectional associations between intake of 100 μg of dietary phylloquinone and inflammatory or metabolic markers at baseline

From: Association between dietary phylloquinone intake and peripheral metabolic risk markers related to insulin resistance and diabetes in elderly subjects at high cardiovascular risk

  Change in inflammatory marker for 100 additional μg of dietary phylloquinone intake (95% confidence intervals) P
C-Peptide (ng/mL) −0.73 (−2.68 to 1.27) 0.472
Ghrelin (pg/mL) −1.25 (−3.76 to 1.33) 0.339
GIP (pg/mL) −0.13 (−2.98 to 2.80) 0.928
GLP-1 (ng/mL) −1.81 (−5.40 to 1.91) 0.335
IL-6 (pg/ml) −1.68 (−5.46 to 2.25) 0.396
Leptin (ng/mL) −1.48 (−3.80 to 0.90) 0.221
PAI-1 (ng/mL) −1.64 (−3.23 to −0.0)2 0.047
Resistin (ng/mL) −1.42 (−3.61 to 0.81) 0.210
TNF (pg/mL) −1.24 (−5.73 to 3.46) 0.598
Visfatin (ng/mL) −1.42 (−6.54 to 3.98) 0.599
Adiponectin (μg/mL) 2.45 (−2.23 to 7.35) 0.310
Adipsin (μg/mL) 1.21 (−2.84 to 5.43) 0.563
  1. Multivariable linear regression models were used for analysis. Data are given in % of change (95% IC). Models are adjusted for sex, age, body-mass-index, smoking (never, current, past), total energy intake (kcal/d), dietary fibre intake (g/d), dietary polyunsaturated fatty acids intake (g/d), physical activity (kcal/d), Mediterranean Diet Score (14-item PREDIMED score, quantitative), and T2DM. GIP Gastric inhibitory polypeptide, GLP-1 Glucagon-like peptide-1, IL-6 Interleukin-6, PAI-1 Plasminogen activator inhibitor-1, TNF Tumor Necrosis Factor α.